3992835566_34a57f6492_o.jpg
Philips delivers Q1 sales of EUR 4.2 billion, with 2% comparable sales decrease; income from continuing operations amounted to EUR 42 million and Adjusted EBITA margin was 5.9%
20 avr. 2020 01h00 HE | Royal Philips
April 20, 2020 First-quarter highlights•        Sales amounted to EUR 4.2 billion, with a 2% comparable sales decrease•        Comparable order intake increased 23%•        Income from continuing...
Philips CEO Frans van Houten speaks at Capital Markets Day 2018
Philips to postpone its Capital Markets Day to the fourth quarter of 2020
31 mars 2020 12h00 HE | Royal Philips
March 31, 2020 Amsterdam, the Netherlands – In connection with the coronavirus disease (COVID-19) outbreak and related precautionary measures, Royal Philips (NYSE: PHG; AEX: PHIA), a...
3992835566_34a57f6492_o.jpg
Philips successfully prices offering of Notes for EUR 1 billion
25 mars 2020 13h15 HE | Royal Philips
March 25, 2020 Amsterdam, the Netherlands – Koninklijke Philips N.V. (“Royal Philips”) (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its...
Feike Sijbesma
Philips convenes the 2020 Annual General Meeting of Shareholders
16 mars 2020 09h30 HE | Royal Philips
March 16, 2020  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today convenes the 2020 Annual General Meeting of Shareholders (AGM) and publishes the agenda with explanatory...
PAI_logo_RGB.png
PAI Health Awarded Contract to Develop and Manage Technology Platform for the World’s Largest Exercise Study
04 mars 2020 10h00 HE | PAI Health
VANCOUVER, British Columbia, March 04, 2020 (GLOBE NEWSWIRE) -- PAI Health, a heart health software company, has been awarded the contract to develop the technology platform for the largest exercise...
Philips Microsoft Augmented Reality HoloLens2 3D navigation
Philips publishes its Annual Report 2019
25 févr. 2020 02h00 HE | Royal Philips
February 25, 2020 Company provides update related to coronavirus disease 2019 (COVID-19) outbreak Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in...
Philips Stellarex low-dose drug-coated balloon
Four-year data from ILLUMENATE Pivotal trial reaffirms safety profile of Philips Stellarex low-dose Drug-Coated Balloon
28 janv. 2020 10h00 HE | Royal Philips
January 28, 2020 Mortality rates similar to standard of care through four years with excellent rate of follow-up compliancePhilips Stellarex is the only low-dose Drug-Coated Balloon (DCB) to...
NewLogo.jpg
Digital Health Study: Estonia overtakes Denmark as European eHealth Champion
09 janv. 2020 04h00 HE | HIMSS
BERLIN, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Cybersecurity, interoperability, and patient empowerment are major concerns in the European healthcare industry, according to the latest “Annual European...
NewLogo.jpg
HIMSS20 Global Conference equips health information and technology changemakers
08 janv. 2020 09h15 HE | HIMSS
CHICAGO, Jan. 08, 2020 (GLOBE NEWSWIRE) -- In a time of unprecedented healthcare disruption, the 2020 HIMSS Global Health Conference & Exhibition calls health information and technology experts...
Gofire-Logo-1080.png
Less Medicine, Better Results: Gofire Beta Testers Report Increased Efficacy Using Precision-dose Technology
06 nov. 2019 09h00 HE | Gofire, Inc.
Controlled convection vaporization process, 2.5 mg incremental dosing decreases waste while enhancing outcomes from plant-based medicines DENVER, Nov. 06, 2019 (GLOBE NEWSWIRE) -- People using the...